Multiplex IHC and Multiplex IF (mIHC and mIF) Service

Biological processes do not occur in isolation. In the complex landscape of tissue pathology—whether in the Tumor Microenvironment (TME), neurodegenerative plaques, or autoimmune lesions—the interplay between immune cells and stromal components is just as critical as their individual presence.

Multiplex Immunohistochemistry (mIHC) and Multiplex Immunofluorescence (mIF) move beyond the limitations of standard single-marker staining. By visualizing multiple targets simultaneously on a single tissue section, these technologies allow researchers to map spatial relationships, define complex cellular phenotypes, and preserve the critical morphological context of the tissue.

Submit Your Request Now

Submit Your Request Now

×
mIF overview diagram
  • How to choose
  • Workflow
  • Panels
  • Customized service

Choosing the Right Modality: mIHC vs. mIF

While both Multiplex Immunohistochemistry (mIHC) and Multiplex Immunofluorescence (mIF) aim to reveal the spatial biology of tissue, they utilize distinct detection systems suited for different investigative needs. Understanding the technical nuances and application scenarios of each is critical for study design.

Feature Multiplex IHC (Chromogenic) Multiplex IF (Fluorescent)
Detection PrincipleEnzyme-mediated deposition of colored precipitates (e.g., DAB, Teal, Red).Fluorophore excitation and emission (often via Tyramide Signal Amplification).
Imaging HardwareStandard Brightfield Microscope / Scanner.Fluorescence Microscope / Multispectral Scanner.
Plex CapabilityTypically limited to 3–4 markers simultaneously to avoid color blending ambiguities.High multiplexing potential (6+ markers) with narrow-band emission filters.
Co-localizationDifficult to quantify; colors mix physically on the slide (e.g., Brown + Red).Excellent; signals are distinct channels that can be digitally overlaid and quantified.
Tissue ContextSuperior visualization of tissue architecture and morphology without digital reconstruction.Good, but relies on nuclear stains (DAPI) or autofluorescence for morphological context.
Data PermanencePermanent; slides do not fade and can be archived for years.Signal can fade (photobleaching) over time; digital archiving is essential.

Workflow of mIHC and mIF

High-order multiplexing requires a shift from traditional "cocktail" staining to a sequential, iterative approach. Whether utilizing the morphological clarity of mIHC or the high-plex capabilities of mIF, our workflow allows for the use of multiple primary antibodies from the same host species without cross-reactivity.

Our optimized protocol follows a cyclic "Stain-Image/Strip-Repeat" logic (for digital mIHC) or a "Stain-Strip-Stain" logic (for mIF), ensuring epitope stability and signal independence.

Phase 1: Foundation (Common to mIHC & mIF)

  • Deparaffinization & Rehydration: Standard tissue preparation.
  • Antigen Retrieval (HIER): A single, robust heating step unmasks epitopes. Our buffers are formulated to protect tissue morphology even through subsequent heating cycles.
  • Blocking: Application of a universal blocking buffer to neutralize endogenous enzymes and prevent non-specific binding.

Phase 2: The Staining Cycle (Repeated for each Target)

  • Primary Antibody Incubation: Binding of the specific primary antibody to the target antigen.
  • HRP-Secondary Introduction: A polymer-HRP secondary antibody binds to the primary.
  • The Divergence Point (Detection):
    • For mIF: A Tyramide-Fluorophore is added. The HRP catalyzes the covalent deposition of the fluorophore directly onto the tissue.
    • For mIHC: A Tyramide-Chromogen or high-sensitivity substrate (e.g., DAB, Teal, Red) is added to create a stable, colored precipitate.
  • Antibody Stripping / Heat Deactivation: The slide is heated. This strips away the primary and secondary antibody complex, but the covalently bound fluorophore remains.

Phase 3: Counterstaining & Imaging

Counterstaining:

  • mIF: DAPI is used to visualize nuclei and assist in cell segmentation.
  • mIHC: Hematoxylin provides the nuclear contrast and anatomical context.

Imaging:

  • mIF: Multispectral scanning or fluorescence microscopy captures distinct spectral channels.
  • mIHC: Standard brightfield scanning captures the composite colored image.

mIHC&mIF workflow

Featured Application Panels

Our multiplex panels are curated to provide deep insights into specific biological mechanisms. By combining structural markers with functional and lineage-specific markers, these panels provide a holistic view of the cellular landscape.

Multiplex IF (Human Validated Panels) (mIFH Panels for human FFPE tissue specimens)

Panel Name Target Markers Primary Application
Checkpoint Panel 1PD-L1, CD8, CD56, IFNγ, SOX10/PanCK, DAPITumor immunity & NK cell profiling
Checkpoint Panel 2GAL9, LAG3, CD8, TIM3, CD155, MHCIIExhaustion & inhibitory receptor mapping
T-Cell ActivationCD3, CD4, CD8, CD45RO, Grzm B, ICOS1, Ki67, DAPIActivation state & memory profiling
T-Helper LineageCD3/CD4, CD8, FoxP3, T-bet, GATA3, RORγ, DAPITh1/Th2/Th17/Treg differentiation
Plasma CellCD3/CD4, CD8, CD20, IgG, CD138, Ki67, DAPIB-cell maturation & antibody secretion
Myeloid PanelCD11b, CD1a, GAL9, CD68, CD83, CD40, DAPIMacrophage/DC polarization & activation
TLS Panel 1CD3/CD4, CD8, CD20, PNAd, DC-Lamp, Ki67Tertiary Lymphoid Structure (TLS) architecture
TLS Panel 2MADCAM, CD8, CD20, PNAd, RORγ, OLIG2, DAPITLS formation & neogenesis
IL-10 PanelCD3/CD4, CD8, CD20, CD34, T-bet, IL-10, DAPIAnti-inflammatory cytokine mapping
Immune SuppressionCD34, IDO1, ARG1, CD39, CD73, DAPIMetabolic suppression & MDSC profiling
Ab ProductionCD3/CD4, CD8, CD20, IFNγ, IgG, Ki67, DAPIFunctional B-cell analysis

Multiplex IF (Mouse (Murine) Validated Panels) (mIFH Panels for murine FFPE tissue specimens)

Panel Name Target Markers Primary Application
Murine TLSCD4, CD8, CD19, CD11c, PNAd, CD34, DAPICharacterizing lymphoid structures in mouse models
Murine T-Cell ActivityCD4, CD8, CD19, Grzm B, CD34, Ki67, DAPICytotoxic activity & proliferation in mice

Multiplex IHC Panels

Panel Name Target Markers Primary Application
T-Cell ActivationCD3, Granzyme B, Ki67, PanCKCytotoxic T-cells in tumor nests
PD-L1 CheckpointCD8, CD68, PD-L1, PanCKPD-L1 status on tumor vs. macrophages
Memory T-CellCD3, CD45RO, PD-1, PanCKExhausted memory cells in TME
APC PanelCD11b, CD68, CD20, MHC IIAntigen presentation landscape

Custom Panel Design Services

Every research hypothesis is unique. While our pre-validated panels cover core applications, novel discoveries often require unique marker combinations.

Developing a multiplex panel is complex; it requires balancing antibody species, fluorophore spectral overlap, and the order of antigen retrieval. Our Custom Panel Design service handles this complexity for you.

Our Service Includes:

  • Consultation: Feasibility assessment of your target markers.
  • Validation: Rigorous testing of antibody specificity and sensitivity.
  • Optimization: Balancing signal-to-noise ratios for every channel.
  • Protocol Transfer: We provide a fully optimized protocol ready for your lab.
* For Research Use Only. Not for use in diagnostic procedures.
Our customer service representatives are available 24 hours a day, 7 days a week. Inquiry

From Our Clients

Online Inquiry

Please submit a detailed description of your project. We will provide you with a customized project plan to meet your research requests. You can also send emails directly to for inquiries.

* Email
Phone
* Service & Products of Interest
Services Required and Project Description

Great Minds Choose Creative Proteomics